Restrained Mitf-associated autophagy by Mulberroside A ameliorates osteoclastogenesis and counteracts OVX-Induced osteoporosis in mice

preprint OA: closed
📄 Open PDF View at publisher
AI-generated summary by claude@2026-07, 2026-07-17

Mulberroside A suppresses osteoclastogenesis and counteracts ovariectomy-induced osteoporosis by inhibiting Mitf-associated autophagy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Background: and Purpose: Overactivated osteoclasts disrupt the mineral homeostasis of bone, inducing osteoporosis. Despite the rapid development of pharmacological therapy in osteoporosis, a safer and more effective treatment remains to be explored. Recently, the connection between osteoporosis and autophagy has gained more attention. Autophagy activation promotes osteoclastogenesis and the development of osteoporosis. Mulberroside A (Mul-A), a natural component extracted from mulberry bark and branches, has various pharmacological functions. Nevertheless, the role of Mulberroside A on osteoporosis and autophagy is unknown. Here, we aimed to investigate the changes in osteoclastogenesis and autophagy occurrence in response to Mulberroside A. Experimental and Approach: TRAP staining and bone resorption assay were used to confirm the inhibitory effect of Mul-A on osteoclastogenesis and function. Western blot, Quantitative real-time PCR, transmission electron microscope and confocal microscope were performed to explore the mechanism. Ovariectomy(OVX) was employed to verify the therapeutic effect of Mul-A on osteoporosis in vivo. Key Results: Mul-A effectively suppresses osteoclastogenesis in vitro and counteracts the bone loss caused by ovariectomy(OVX). Mechanically, Mul-A represses the occurrence of autophagy flux during osteoclastogenesis, which can be attributed to the restrained expression of microphthalmia-related transcription factor(Mitf) and its nuclear translocation. Moreover, the application of two autophagy agonists, rapamycin and Torin 1, attenuates the osteoclastogenic regulatory role of Mul-A as well. Conclusions and Implications: Our study demonstrates that Mul-A damages the differentiation of osteoclasts and ameliorates osteoporosis caused by estrogen deficiency through modulation of Mitf-associated autophagy, suggesting its therapeutic potential against osteoporosis.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00